For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

A new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS ... increased degeneration of nerve cells – a hallmark of advancing MS – and ...

Multiple sclerosis (MS) is a chronic condition affecting the central nervous system. Its symptoms range from mild and intermittent to severe and permanently damaging. There’s currently no cure ...

Early signs and symptoms of multiple sclerosis (MS) can vary for each person. MS onset symptoms can include vision issues, weakness, tingling, numbness, and more. MS is a relapsing or progressive ...

An investigational drug for multiple sclerosis from Io Therapeutics has ... that normally surrounds nerve cells. Without this protection, nerves degrade, leading to symptoms like muscle weakness ...

The use of stem cells may open a new era in the management of multiple sclerosis (MS) and other neurodegenerative and neuroimmunological disorders. In the case of MS, the potential of stem cells ...

They report a concerning relationship between micro and nanoplastic (MNP) concentrations in damaged tissues and links with multiple health conditions. Plastic usage soared from 1.5 million metric ...